Skip to main content

#151568

Anti-TFF1 [PS2GE1]

Cat. #151568

Anti-TFF1 [PS2GE1]

Cat. #: 151568

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Trefoil factor 1 (TFF1) also known as pS2/pNR2 Estrogen-regulated protein Ab2

Class: Monoclonal

Application: IHC ; IP

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-TFF1 [PS2GE1]
  • Research fields: Cancer;Cell biology;Genetics
  • Clone: PS2GE1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 6.5 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; IP
  • Description: pS2 is a cysteine-rich, 6.5kDa protein found in both oestrogen-dependent (breast tumours) and oestrogen-independent tissues (normal stomach mucosa). About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localisation to the Golgi apparatus. pS2 is primarily expressed in oestrogen receptor-positive breast tumours.
  • Immunogen: A synthetic 31-mer peptide from the C-terminus of human pS2 protein
  • Isotype: IgG1
  • Recommended controls: Normal stomach or breast carcinoma

Target Details

  • Target: Trefoil factor 1 (TFF1) also known as pS2/pNR2 Estrogen-regulated protein Ab2
  • Molecular weight: 6.5 kDa
  • Tissue cell line specificity: Normal stomach or breast carcinoma
  • Target background: pS2 is a cysteine-rich, 6.5kDa protein found in both oestrogen-dependent (breast tumours) and oestrogen-independent tissues (normal stomach mucosa). About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localisation to the Golgi apparatus. pS2 is primarily expressed in oestrogen receptor-positive breast tumours.

Applications

  • Application: IHC ; IP

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Williams et al. 1996. Hum Pathol. 27(12):1259-66. PMID: 8958295.
  • Characterization of monoclonal antibodies raised to C-terminal peptides of pS2: a major trefoil peptide and motility factor expressed in adenocarcinomas and regions of mucosal injury.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.